Botulinum toxin use in patients with post-stroke spasticity: a nationwide retrospective study from France

BackgroundCurrent guidelines recommend intramuscular botulinum toxin type A (BoNT-A) injection as first-line treatment for spasticity, a frequent and impairing feature of various central nervous system (CNS) lesions such as stroke. Patients with spasticity commonly require BoNT-A injections once eve...

Full description

Bibliographic Details
Main Authors: Jonathan Levy, Pierre Karam, Anne Forestier, Jean-Yves Loze, Djamel Bensmail
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1245228/full